Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Recent patent covers antiinflammatory agents from Ajinomoto

Feb. 22, 2001

FDA advisory committee recommends changes in Vioxx and Celebrex labeling

Feb. 22, 2001

Merck reports compounds with the ability to inhibit cytokine production or activity

Feb. 21, 2001

AtheroGenics moves second product into clinical development

Feb. 21, 2001

Review of Aslera NDA rescheduled for April

Feb. 21, 2001

Sankyo presents new cytokine production inhibitors in recent patent

Feb. 20, 2001

Cytokine inhibitors in the Merck pipeline

Feb. 19, 2001

Toleragen candidate for APS reduces disease-causing antibodies, corrects clotting defect in animals

Feb. 16, 2001

Preparation, activity and use of specific IkappaB kinase inhibitors claimed by Aventis

Feb. 15, 2001

Beneficial effects of long-term glucosamine sulfate on osteoarthritis progression

Feb. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.